Cell Source (CLCS) Stock Statistics & Valuation Metrics
Total Valuation
Cell Source has a market cap or net worth of $36.49M. The enterprise value is $45.08T.
- Market Cap
- $36.49M
- Enterprise Value
- $45.08T
Share Statistics
Cell Source has 68,857,376 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 68,857,376
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Cell Source’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 28.75%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- -9.99
- Return on Invested Capital (ROIC)
- 28.75%
- Return on Capital Employed (ROCE)
- 0.12
- Revenue Per Employee
- 0
- Profits Per Employee
- -4.64M
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Cell Source is -5.30. Cell Source’s PEG ratio is -0.99.
- PE Ratio
- -5.30
- PS Ratio
- 0.00
- PB Ratio
- -1.28
- Price to FCF
- -13.18
- Price to Operating Cash Flow
- -10.55
- PEG Ratio
- -0.99
Income Statement
In the last 12 months, Cell Source had revenue of 0 and earned -4.64M in profits. Earnings per share was -0.10.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -2.73M
- Pretax Income
- -4.64M
- Net Income
- -4.64M
- EBITDA
- -2.73M
- Earnings Per Share (EPS)
- -0.10
Cash Flow
In the last 12 months, operating cash flow was -2.68M and capital expenditures 0, giving a free cash flow of -2.68M billion.
- Operating Cash Flow
- -2.68M
- Free Cash Flow
- -2.68M
- Free Cash Flow per Share
- -0.05
Dividends & Yields
Cell Source pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -7.59%
- Earnings Yield
- -16.10%
Stock Price Statistics
- Beta
- -0.46
- 52-Week Price Change
- 42.97%
- 50-Day Moving Average
- 0.53
- 200-Day Moving Average
- 0.75
- Relative Strength Index (RSI)
- 52.89
- Average Volume (3m)
- 3,586
Financial Position
Cell Source as a current ratio of 0.02, with Debt / Equity ratio of -57.79%
- Current Ratio
- 0.02
- Quick Ratio
- 0.02
- Debt to Market Cap
- 0.48
- Net Debt to EBITDA
- -4.59
- Interest Coverage Ratio
- -1.34
Taxes
In the past 12 months, Cell Source has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Cell Source EV to EBITDA ratio is -17.80, with an EV/FCF ratio of -17.77.
- EV to Sales
- 0.00
- EV to EBITDA
- -17.80
- EV to Free Cash Flow
- -17.77
- EV to Operating Cash Flow
- -17.77
Balance Sheet
Cell Source has $74.63K in cash and marketable securities with $10.07M in debt, giving a net cash position of -$9.99M billion.
- Cash & Marketable Securities
- $74.63K
- Total Debt
- $10.07M
- Net Cash
- -$9.99M
- Net Cash Per Share
- -$0.15
- Tangible Book Value Per Share
- -$0.42
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Cell Source is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
